Brought to you by 
Series A brings in $13.6mm for Quinnova Pharmaceuticals
13 Dec 2006
Executive Summary
Quinnova Pharmaceuticals (specialty drugs for dermatological conditions; drug reformulation technologies) has raised $13.6mm through its Series A venture round. Omnivest led and was joined by Thomas, McNerney & Partners and HIG Ventures. Salem Partners served as placement agent for the transaction.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
-
Drug Delivery
- Topical Delivery
- Transdermal
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Series A brings in $13.6mm for Quinnova Pharmaceuticals
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice